Mycobacterial infections (TB) Flashcards

1
Q

Difference b/t acute and chronic cough?

A
  • acute cough: only exists for less than 3 weeks and is most commonly due to an acute respiratory tract infection. Other considerations include and acute exacerbation of underlying chronic pulmonary disease, pneumonia, and PE
  • Chronic: cough that has been present longer than 3 weeks is either subacute (3-8 weeks) or chronic (more than 8 weeks)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common causes of chronic cough

A
  • post nasal drip from allergies or chronic sinusitis
  • asthma
  • postinfectious
  • chronic bronchitis
  • GE reflux
  • heart failure
  • medication induced (ACE inhibitors)
  • enviro irritants -> pollution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mycobacteria infections

A
  • Mycobacterium TB
  • Mycobacterium Leprae
  • Atypical & nontubercular mycobacterium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Definition of TB

A
  • an infectious disease caused by the tubercle bacillus, Mycobacterium tb, and characterized pathologically by inflammatory infiltrations, formation of tubercles, caseation, necrosis, abscesses, fibrosis and calcification
  • most commonly affects the respiratory system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of stain do you use to dx TB

A
  • Acid fast bacilli stain

mycelia acid which makes up the wall of mycobacterium take up acid fast stain (won’t show up in gram - or + stains)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TB epidemiology

A
  • TB is one of world’s deadliest disease:
    1/3 of world’s pop is infected with TB
  • each year over 9 mill people around the world are afflicted with TB
  • each year, almost 2 mill TB related deaths worldwide
  • TB is leading killer of individuals who have HIV

-Incidences of TB in the U.S> has been decreasing.
Increase in 1992 (18% increase compared to 1985) associated with HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is the rate of TB declining in the U.S.?

A
  • yes, the TB rate has been going down in U.S. each year since 1992
  • the average annual % decline in the TB rate slowed from 6.6% for 1993 through 2002, to an avg decline of 3.4% for 2003 - 2008
  • rate from 2013: 3.2%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Who accounts for most of the increase of TB cases?

A
  • HIV patients account for 30-50% of increase

- HIV is the greatest known RF for reactivating latent TB infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where has TB become prevalent?

A
  • prevalent in populations co-infected with HIV and M. tuberculosis, such as inner city minority and injection drug users
  • in some inner city tb clinics: 40% of all pts with TB are infected with HIV
  • TB in foreign born individuals accounted for 53% of cases in 2004 (mexico, philippines, Vietnam, India and China)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

4 possible outcomes of TB infection

A
  1. immediate clearance of the organism
  2. chronic or latent infection (gets past initial immunity barriers into lungs)
  3. Rapidly progressive disease (primary disease -> rapidly spreads throughout lungs, may spread to other organs)
  4. Active disease many years after the infection (reactivation disease) may lay dormant for many years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Chronic (latent) infection

A
  • person comes in with positive PPD but is asymptomatic with clear CXR
  • Person is infected but not infectious
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Primary disease

A
  1. small bacilli carried in droplets small enough to reach alveolar space
  2. If host system fails in clearing:
    - Bacilli proliferate inside alveolar macrophages and kill the cells
    - infected macrophages produce cytokines and chemokines that attract other phagocytic cells, including monocytes, other alveolar macrophages, and neutrophils, which eventually form a nodular granulomatous structure called the tubercle or Gohn focus
    - if the bacterial replication isn’t controlled, the tubercle enlarges and the bacilli enter the local draining lymph nodes, this leads to lymphadenopathy, a characteristic manifestation of primary TB
    - Caseation/fibrosis/calcification: ghon complex
    (caseation: necrosis of cells (look like cheese in middle of complex)
    - calcification is imp step in containing bacterium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

steps of Primary disease infection

A
  1. bacilli reach alveolar space
  2. proliferation inside macrophages
  3. initial inflammatory granulomatous tubercle formation (if bacterial replication is controlled here, pt will not develop primary disease and is said to have chronic or latent infection)
  4. Enlargement of tubercle and infiltration of lymph system (Gohn complex: describes an inflammatory nodule in the pulmonary parenchyma (Gohn focus) with an accompanying hilar adenopathy, in line with lymphatic drainage from the pulmonary segment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptomatic primary disease

A
  • those who develop active disease w/in 2-3 years after infection
  • sever illness: lung necrosis, and extrapulmonary involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Main symptoms of pulmonary TB?

A

Central: appetite loss, and fatigue
lungs: chest pain, coughing up blood, productive and prolonged cough
Skin: night sweats, pallor (anemia from chronic disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

steps of secondary/reactivation TB

A
  1. asymptomatic primary infection occurs
  2. cell-mediated immunity: has contained the infection (neutrophils, macrophages -> gohn complex probably present)
  3. dormancy
  4. then, recurrence may occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When does secondary/reactivation disease occur and what is it associated with?

A
  • results when the persistent bacteria in a host suddenly proliferate (no longer contained b/c decreased immunity)
  • clearly assoc. with immunosuppression and can be seen in the following circumstances:
    HIV infection and AIDs
    end stage renal disease
    diabetes mellitus
    malignant lymphoma
    corticosteroid use
  • in contrast to primary disease: the disease process in reactivation TB tends to be localized, there is little regional lymph node involvement and the lesion typically occurs at the lung apices (where gohn lesion resided)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Signs and symptoms of secondary/reactivation of TB

A
cough, hemoptysis
persistent fever/night sweats
wt loss
malaise
adenopathy
pleuritic chest pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a Rasmussen aneurysm in TB?

A
  • develops aneurysm and it ruptures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is Miliary TB?

A
  • if the bacterial growth continues to remain unchecked, the bacilli may spread hematogenously to produce disseminated TB
  • lung looks like it is covered with millet seeds
  • Miliary TB is used to denote all forms of progressive, widely disseminated hematogenous TB even if the classical pathologic or radiologic findings are absent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Acute and Chronic Miliary TB

A

Acute (primary infection)

  • high fevers, night sweats, Occ. Resp. distress, septic shock, multigrain failure
  • acute tend to be young

Chronic: reactivation TB
- fever, anorexia, wt loss, particularly in the elderly (FTT)

22
Q

Extrapulmonary manifestations

A
  • frequency is increasing
  • past hx is unreliable
  • 50% have normal chest radiographic findings
  • clinical features vary widely
  • most common type is infection of an individual organ system (bowel, bone, spleen, brain -> depends on where disease is expressed in the body)
    -in most cases, same regimens used for pulmonary TB are used
    systems that can be effected:
  • pleural/pericardial effusions (can lead to pericardial constriction)
  • lymph node infection: tuberculous lymphadenitis -> scrofula, seen in younger pts
  • kidney
  • skeletal: 35% -> potts disease
  • joints
  • CNS tuberculosis: meningitis, intracranial tuberculoma (mass lesion on the brain), spinal tuberclous arachnoiditis (similar to meningitis, arachnoid specific)
    intraabdominal TB: GI tract, peritoneum, renal TB, testicular granuloma
  • TB retinitis
  • muscles: (ex: psoas)
23
Q

Dx of TB

A

dx in most cases are clinical

  • most persons dx w/ TB are begun on specific tx before dx is confirmed by the laboratory because it takes a long time to confirm dx
  • Around 15-20% of pts that are given a presumptive TB dx never have bacteriologic confirmation of disease
24
Q

What can you say if person has positive PPD (mantoux)?

A
  • has had exposure to TB infection
25
Q

What kind of technique is used to examine sputum for TB?

A
  • Ziehl neelsen test

- takes a long time to culture mycobacterium

26
Q

TB skin test?

A
  • generally used as screening test, most sensitive test for dx of infection with mycobacterium TB
  • far more sensitive than a chest radiography
    • TB skin test doesn’t by itself prove the presence of active disease but does indicate that infection has occurred
  • negative reactions have been doc. in 20% of pts who have TB
  • Primary use in detection of Latent TB infection
  • testing is targeted in persons at high risk for developing symptomatic TB who would benefit by tx of LTBI or those pts at increased risk for primary TB should they acquire infection
  • test is discouraged in those at low risk
27
Q

Importance of TB skin test technique?

A
  • must be done intradermally ( b/c confined area: protein derivative where T cells can get to)
  • Must form a visible wheal with injection (subcutaneous admin. will result in a false-neg. test if the pt indeed has been infected by TB)
28
Q

How to read the TB skin test properly?

A
  • must be read 48-72 hours (reaction is from delayed type hypersensitivity response mediated by T lymphocytes)
  • test is read by the diameter of the induration, not the diameter of the erythema
  • finger vs ballpoint pen method
29
Q

Indicaions for TB skin testing?

A
  • HIV infection
  • ongoing close contact with cases of active TB:
    health care workers
    prison guards
    mycobacterial lab personnel
    Presence of medical condition that increases risk of active TB: DM, steroid therapy, other immunosuppressive agents, certain types of malignancies, end stage renal disease, alcoholism, suppressed immune systems
  • medically underserved, low income population:
    homeless, injection drug users
  • residence in long term care facility: nursing homes, correctional institutions, mental institutions
  • single potential exposure to TB ( dx of TB of family member): repeat testing in 6-12 weeks if pt tested shortly after exposure
  • presence of incidentally discovered fibrotic lung lesion
  • immigrants and refugees from countries with high prevalence of TB
30
Q

Sources of false-negative tests

A
  • inadequate nutrition
  • anergy
  • nontubercular mycobacterium (bovus and avian)
  • simultaneous presence of immunosuppressive disorder
  • concurrent viral infection
  • corticosteroid therapy
31
Q

Who would be considered for + TB skin test with induration > 5 mm

A
  • HIV positive persons
  • recent contacts of TB case
  • fibrotic changes on chest radiograph consistent with old TB
  • pts with organ transplants and other immunosuppressed pts ( receiving >15 mg/d prednisone for > 1 month)
32
Q

Who would be considered + for TB test with induration > 10 mm

A
  • recent arrivals (10 %, gastrectomy, jejunolieal bypass

- children

33
Q

Who is considered + for TB with >15 mm induration?

A
  • persons with no RFs for TB
34
Q

+ TB skin test w/ BCG vaccine?

A
  • children who received this vaccine generally demonstrate PPD reactions of 3-19 mm several months after vaccination
  • TB skin testing is not CI in BCG vaccinated persons: baseline testing should be done several months following vaccination
  • subsequent tests can be compared to baseline tests to eval. likelihood of true TB infection
  • responses indicative of new TB infection include:
  • increase in skin test reactivity > 10 mm induration in persons less than 35 yo
  • increases in reactivity of > 15 mm induration in persons greater than 35 yo
  • if baseline values unavailable: reactivity should be interpreted and tx as for unvaccinated persons
35
Q

When should the sputum be evaluated?

A
  • when active disease is suspected, there should be an exam of sputum for Acid Fast Bacilli staining and mycobacterium culturing
  • if pt unable to produce sputum spontaneously attempts should be made to induce sputum:
    hydration
    pulmonary physiotherapy
    mucolytic agents
    bronchoscopy or bronchoalveolar lavage
  • impt test: gold standard dx test: culture bacilli
36
Q

Acid Fast Bacilli staining

A
  • Mycobacterium have a cell envelope, unlike gram - bacteria, there is no true outer membrane in mycobacterium, the envelope is composed of a number of different macromolecules including mycolic acid
  • AFB smear: makes presumptive dx of TB in high risk pt
  • not specific for Mycobacterium TB (other acid-fast organisms will be positive such as mycobacterium avium and bonus)
  • 2 versions: fluorchrome staining: decreases exam time and increases sensitivity versus Ziehl-Neelsen method but is expensive
    Ziehl Neelsen method (older)
37
Q

Mycobacterium culturing

A
  • gold std of dx of TB
  • slow growth rate

Solid media: lowenstein- Jensen or Middlebrook
- takes up to 8 weeks or longer to detect growth

Liquid media: expensive, broth formulations, more rapid and can detect growth of mycobacteria in clinical samples in as few as seven days

38
Q

Other screening test for TB

A
  • whole blood interferon gamma assay (Quantiferon-TB Gold test)
  • screening test for asymptomatic disease
  • T cells of individuals previously sensitized with TB AGs will produce interferon gamma when they reencounter mycobacterial AGs
  • 99% accurate reading
  • can be used in all circumstances in which PPD is used (have negative PPD and have been exposed)
39
Q

Advantages of Quantiferon-TB gold test over skin test?

A
  • subject to less testing error
  • subject to less reader bias and error
  • can be accomplished after a single pt visit
  • may not be as likely to be positive following BCG vaccination
  • The RD1 AGs used in this testing are not shared with most nontuberculous mycobacteria (bonus and avium)
40
Q

Rapid nucleic acid assays?

A
  • Can produce results within 2-7 hours after sputum processing
  • requires higher level labs
  • highly specific for Mycobacterium TB and is generally recommended on all AFB smear-positive respiratory specimens
    • nucleic acid assay of AFB smear positive respiratory sample is dx of TB
41
Q

Characteristics of mycobacterium

A
  • rod shaped bacteria with lipid rich cell walls

- they grow very slowly and take a long time to eradicate with antibacterials

42
Q

TB management for latent infection

A
  • 9 months of Isoniazid

alt: Rifampin PO daily for 4 months

43
Q

Tb management for reactivation TB disease

A
  • requires at least 2 effective drugs b/c of increased incidence of drug resistance
  • Initial therapy of active TB include 4 drugs:
  • INH
  • RIF
  • Pyrazinamide (PZA)
  • Ehtambutol (EMB)
44
Q

MOA of INH

A
  • covalently binds to and inhibits enzymes essential for synthesis of mycolic acid
  • very specific to TB b/c of mycelia acid cell envelope
  • never used alone as resistant organisms will rapidly emerge
    AEs:
    hepatotoxicity: monitor liver enzymes
  • most common SE: peripheral neuritis which manifests as paresthesias and is assoc. with pyridoxine ( Vit B6) deficiency
45
Q

MOA of Rifampin

A
  • broader antimicrobial activity than INH
  • blocks transcription by interfering with the beta subunit of bacterial RNA polymerase
  • in add. to mycobacteria -> effective against many gram + and - bacteria (frequently used prophylactically for individuals exposed to meningitis caused by meningococci or H. influenzae
  • AEs: hepatotoxicity, liver enzymes
    inducer of cytochrome P450 enzymes and therefore the pt may need higher dosage requirements for other drugs metabolized by this system
46
Q

MOA of Pyrazinamide

A
  • unknown
  • only seen in anti tubercular combo packages
  • AE: extensively metabolized by liver, must watch for hepatotoxicity
  • gout
47
Q

MOA of ethambutol (EMB)

A
  • inhibits an enzyme important for the synthesis of the mycobacterial arabinogalactan cell wall
  • AEs:
    optic neuritis: results in diminished visual acuity and loss of ability to discriminate from red and green
  • eye exams regularly (every couple of weeks)
48
Q

Alt. second line drugs for TB

A
  • aminsalicylic acid
  • capreomycin
  • cylcoserine
  • ethionamide
  • fluoroquinolones*
  • macrolides*

(used outside of TB tx)

49
Q

Resistance to TB drugs

A
  • multi drug resistance: Isoniazid and Rifampin

Extremely drug resistance: use Isoniazid, Rifampin, a fluoroquinolone, and injectable (amino glycoside)

  • requires ID specialist
  • 18-24 months tx
  • surgery often required
50
Q

Why are there pt compliance issues?

A
  • b/c sxs are often gone w/in 2 months of initiating multi drug therapy yet the pt must continue therapy for 6 months - 2 years before organism is fully eradicated
  • ## TB occurs with a higher incidence in several pt populations that show higher noncompliance (injection drug users)
51
Q

What can help with compliance issues?

A

DOT therapy: directly observed therapy

  • trained health care worker or other designated individual (excluding family member) provides the prescribed TB drugs and watches pt swallow every dose
  • nurse or supervised outreach worker from county public health dept can provide DOT